These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 36325491)
1. Epstein-Barr virus infection, B-cell dysfunction and other risk factors converge in gut-associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis. Leffler J; Trend S; Hart PH; French MA Clin Transl Immunology; 2022; 11(11):e1418. PubMed ID: 36325491 [TBL] [Abstract][Full Text] [Related]
2. Circulating Memory B Cells in Early Multiple Sclerosis Exhibit Increased IgA Leffler J; Trend S; Ward NC; Grau GE; Hawke S; Byrne SN; Kermode AG; French MA; Hart PH Front Immunol; 2022; 13():812317. PubMed ID: 35250986 [TBL] [Abstract][Full Text] [Related]
3. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis. Veroni C; Aloisi F Front Immunol; 2021; 12():665718. PubMed ID: 34305896 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism. Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Induces Expression of the LPAM-1 Integrin in B Cells Delecluse S; Tsai MH; Shumilov A; Bencun M; Arrow S; Beshirova A; Cottignies-Calamarte A; Lasitschka F; Bulut OC; Münz C; Zeier M; Behrends U; Delecluse HJ J Virol; 2019 Mar; 93(5):. PubMed ID: 30541846 [TBL] [Abstract][Full Text] [Related]
6. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis. Otto C; Hofmann J; Ruprecht K Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157 [TBL] [Abstract][Full Text] [Related]
7. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis. Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM Front Immunol; 2021; 12():757302. PubMed ID: 34790199 [TBL] [Abstract][Full Text] [Related]
9. Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis. Läderach F; Münz C Cells; 2022 Sep; 11(17):. PubMed ID: 36078165 [TBL] [Abstract][Full Text] [Related]
10. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15. Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis. Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F J Neuroinflammation; 2018 Jan; 15(1):18. PubMed ID: 29338732 [TBL] [Abstract][Full Text] [Related]
12. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Pender MP; Burrows SR Clin Transl Immunology; 2014 Oct; 3(10):e27. PubMed ID: 25505955 [TBL] [Abstract][Full Text] [Related]
14. CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation. Dragon AC; Zimmermann K; Nerreter T; Sandfort D; Lahrberg J; Klöß S; Kloth C; Mangare C; Bonifacius A; Tischer-Zimmermann S; Blasczyk R; Maecker-Kolhoff B; Uchanska-Ziegler B; Abken H; Schambach A; Hudecek M; Eiz-Vesper B J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33127653 [TBL] [Abstract][Full Text] [Related]
15. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621 [TBL] [Abstract][Full Text] [Related]
17. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes. Pender MP; Csurhes PA; Pfluger CM; Burrows SR BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis. Laurence M; Benito-León J Mult Scler Relat Disord; 2017 Aug; 16():8-14. PubMed ID: 28755684 [TBL] [Abstract][Full Text] [Related]
19. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129 [TBL] [Abstract][Full Text] [Related]
20. Exploring the effect of vitamin D Rolf L; Muris AH; Mathias A; Du Pasquier R; Koneczny I; Disanto G; Kuhle J; Ramagopalan S; Damoiseaux J; Smolders J; Hupperts R Mult Scler; 2018 Sep; 24(10):1280-1287. PubMed ID: 28731372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]